Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Free Cash Flow (2021 - 2025)

Senti Biosciences has reported Free Cash Flow over the past 5 years, most recently at -$6.9 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 49.13% year-over-year to -$6.9 million; the TTM value through Dec 2025 reached -$43.6 million, down 5.35%, while the annual FY2025 figure was -$43.6 million, 5.35% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$6.9 million at Senti Biosciences, up from -$9.4 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$934675.0 in Q2 2021 and troughed at -$33.6 million in Q3 2022.
  • A 5-year average of -$11.6 million and a median of -$9.4 million in 2025 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: plummeted 1862.94% in 2022 and later soared 84.51% in 2023.
  • Year by year, Free Cash Flow stood at -$4.5 million in 2021, then tumbled by 290.69% to -$17.5 million in 2022, then skyrocketed by 59.81% to -$7.0 million in 2023, then tumbled by 91.73% to -$13.5 million in 2024, then soared by 49.13% to -$6.9 million in 2025.
  • Business Quant data shows Free Cash Flow for SNTI at -$6.9 million in Q4 2025, -$9.4 million in Q3 2025, and -$13.1 million in Q2 2025.